1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CELF4 CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA ZNF302 CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA KCNC1 CTRPv2 pan-cancer AAC 0.24 2e-09
mRNA IGFBPL1 CTRPv2 pan-cancer AAC 0.23 2e-09
mRNA CDH24 CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA DOK2 CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA ZNF516 CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA TSNARE1 CTRPv2 pan-cancer AAC 0.21 3e-09
mRNA LDOC1L CTRPv2 pan-cancer AAC 0.23 3e-09
mRNA PLPPR3 CTRPv2 pan-cancer AAC 0.21 3e-09
Download CSV